Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04420143 · ClinicalTrials.gov registry record
MLX/XLX ACR Expandable Lumbar Interbody Implants
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 109
- Enrollment target
NCT04420143: Completed study, sponsored by NuVasive.
NCT04420143 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04420143 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and performance of thoracic and/or lumbar spine surgery using the MLX and XLX ACR interbody implants as measured by reported complications, radiographic outcomes, and clinical patient outcomes. This study is being undertaken to identify possible residual risks and to clarify mid- to long-term clinical performance that may affect the benefit/risk ratios of the MLX and XLX ACR interbody implants.
Primary Outcome
Rate of complications (i.e., safety) attributable to use of the associated interbody implants (MLX or XLX ACR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2020-01-27 |
| Est. Completion | 2020-10-23 |
What the finished NCT04420143 record still lists
NCT04420143 is an observational study that tracks outcomes without assigning an intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04420143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04420143 about?
NCT04420143 is a clinical study titled "MLX/XLX ACR Expandable Lumbar Interbody Implants". The objective of this study is to evaluate the safety and performance of thoracic and/or lumbar spine surgery using the MLX and XLX ACR interbody implants as measured by reported complications, radiographic outcomes, and clinical patient outcomes. This study is being undertaken to identify possible ...
What is the current status of trial NCT04420143?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2020-01-27. Estimated completion is 2020-10-23.
Who is sponsoring clinical trial NCT04420143?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI